Sildalis (sildenafil + tadalafil)

Sildalis is recorded as sildenafil 100 mg plus tadalafil 20 mg. Unlike the other combinations in this directory, it joins two PDE5 inhibitors rather than adding a medicine associated with premature-ejaculation treatment.

What distinguishes this product

The source title says Sildalis while its summary uses Sildalist; the sampled package image says SILDALIS. We retain the source-title identity and record the spelling conflict rather than inventing a confirmed alias or manufacturer. Do not combine PDE5 medicines on the basis of their separate ingredient records.

Product record

Record type: Named product / formulation claim
Treatment area in this directory: Erectile dysfunction (ED)
Active ingredient: sildenafil tadalafil
Formulation in the cited record: Oral tablet
Source-listed strengths: Sildenafil 100 mg + Tadalafil 20 mg
Company in the cited record: Not established for this exact named presentation
Manufacturing information: A specific manufacturing site is not established by the cited catalogue record. Consult the country-specific label and pack.
Market evidence: Global reference; exact market authorization not established by this catalogue import
Storage reported by source: Store between 15°C and 30°C Check the supplied leaflet for the exact presentation.
Catalogue reviewed: 2026-10-03

Catalogue attributes describe the named product as reported by the source. Listed strengths are identification details, not dosing instructions. Ingredient evidence and company identity are useful signals; local product authorization is a separate question.

Component amounts in the source

sildenafil: 100 mg
tadalafil: 20 mg

Ingredient references

These references cover the active ingredients. They do not verify every named brand, pack or formulation listed on this page.

How the ingredients fit treatment

Sildenafil supports the erection response to sexual stimulation by inhibiting PDE5. It is used before sexual activity in ED treatment; it is not a libido stimulant. Food can affect the response, so use the instructions for the prescribed presentation.

Tadalafil is a PDE5 inhibitor with a longer duration of action than sildenafil. Its documented ED regimens include daily and as-needed treatment, using different prescribed strengths. A catalogue strength alone does not identify which regimen is appropriate.

Ingredient guidance and safe use

Read the ingredient guidance alongside the leaflet for the actual product. A different brand, strength or dosage form may need different instructions.

Do not combine a PDE5 inhibitor with nitrates, recreational nitrites (“poppers”) or riociguat. Seek urgent medical help for chest pain, an erection lasting more than four hours, or sudden loss of vision or hearing. Tell the treating team which medicine you took and when.

Commonly reported effects of oral PDE5 medicines include headache, flushing, indigestion and nasal congestion; the pattern varies by ingredient and product. The cited ingredient information covers adverse effects and restrictions in more detail.

A fixed combination needs assessment of every ingredient and their use together. Approval of either ingredient separately does not establish that the combination is suitable. Do not add another ED medicine to it without medical advice.

Interactions and urgent symptoms · Understanding formulations · Finding a local medicine record